BANK VONTOBEL/CALL/NOVO NORDISK ADR B/190/0.1/17.01.25 Share Price

Warrant

DE000VD0JWF3

Market Closed - Deutsche Boerse AG 19:01:55 28/06/2024 BST
0.32 EUR -3.03% Intraday chart for BANK VONTOBEL/CALL/NOVO NORDISK ADR B/190/0.1/17.01.25
Current month+68.42%
1 month+62.44%
Date Price Change
28/06/24 0.32 -3.03%
27/06/24 0.33 -2.94%
26/06/24 0.34 -15.00%
25/06/24 0.4 +37.93%
24/06/24 0.29 -3.33%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 07:01 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VD0JWF
ISINDE000VD0JWF3
Date issued 19/02/2024
Strike 190 $
Maturity 17/01/2025 (201 Days)
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.55
Lowest since issue 0.147
Delta0.19x
Omega 7.980
Premium35.23x
Gearing42.39x
Moneyness 0.7526
Difference Strike 47.26 $
Difference Strike %+24.87%
Spread 0.01
Spread %3.13%
Intrinsic value 0.000000

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006 DKK
Average target price
949.7 DKK
Spread / Average Target
-5.56%
Consensus